Search | TVST | ARVO Journals

Showing 1 – 20 of 130

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Retina June 2024

Perimacular Atrophy Following Voretigene Neparvovec-Rzyl Treatment in the Setting of Previous Contralateral Eye Treatment With a Different Viral Vector

PDF

Cristy A. Ku; Austin D. Igelman; Samuel J. Huang; Steven T. Bailey; Andreas K. Lauer; Jacque L. Duncan; Richard G. Weleber; Paul Yang; Mark E. Pennesi
TAGS: atrophy, chorioretinal atrophy, eye, genes, viral vector, voretigene neparvovec, visual fields
Trans. Vis. Sci. Tech.. 2024; 13(6):11. https://doi.org/10.1167/tvst.13.6.11

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2024

Longitudinal Change in Cone Structure and Retinal Sensitivity in Choroideremia

Liangbo Linus Shen; Yi Zhang; Jessica Wong; Katharina G. Foote; Travis Porco; Ruikang K Wang; Austin Roorda; Jacque L Duncan

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):405.

ARVO Annual Meeting Abstract June 2024

Repeatability and reliability of cone density measures in patients with retinitis pigmentosa (RP) or Usher syndrome using adaptive optics scanning light ophthalmoscopy (AOSLO)

Joseph Kreis; Jessica Wong; Emma Warr; Danica Nikezic; Brea D Brennan; Robert F Cooper; Jacque L Duncan; Joseph Carroll

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1426.

ARVO Annual Meeting Abstract June 2024

Strategies for Evidence-based Variant Curation for LCA and Early Onset Retinal Dystrophy

Lori S Sullivan; Kristy Lee; William Hankey; Radha Ayyagari; Jacque L Duncan; Andrew Webster

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4655.

ARVO Annual Meeting Abstract June 2024

PRPH2 Gene Mutations and Associated Phenotypes in IRD patients with diverse genetic background.

Christopher Hallock; Riccardo Sangermano; Elfride De Baere; Siying Lin; Jennifer Thompson; Pascal Escher; Andrea L Vincent; Kaylie D Webb-Jones; Monika Grudzinska Pechhacker; Jacque L Duncan; Samer Khateb; Tamar Ben-Yosef; David G Birch; Andrew Webster; Radha Ayyagari

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5297.

Retina June 2024

Self-Reported Functional Vision in USH2A -Associated Retinal Degeneration as Measured by the Michigan Retinal Degeneration Questionnaire

PDF

Bela Parekh; Jacque L. Duncan; Lassana Samarakoon; Michele Melia; Maria Fernanda Abalem; Chris A. Andrews; Isabelle Audo; Allison R. Ayala; Chris Bradley; Janet K. Cheetham; Gislin Dagnelie; Todd A. Durham; Rachel M. Huckfeldt; Gabrielle D. Lacy; Brett Malbin; Michel Michaelides; David C. Musch; Nicholas Peck-Dimit; Katarina Stingl; Christina Y. Weng; Alex Z. Zmejkoski; K. Thiran Jayasundera; for the Foundation Fighting Blindness Clinical Consortium Investigator Group
TAGS: michigan, questionnaires, retinal degeneration, self-report, vision, vision tests
Invest. Ophthalmol. Vis. Sci.. 2024; 65(6):5. https://doi.org/10.1167/iovs.65.6.5

Includes: Supplemental Content

Retina July 2023

Enhanced S-Cone Syndrome: Elevated Cone Counts Confer Supernormal Visual Acuity in the S-Cone Pathway

PDF

Yiyi Wang; Jessica Wong; Jacque L. Duncan; Austin Roorda; William S. Tuten
TAGS: enhanced s-cone syndrome, retinal cone, visual acuity
Invest. Ophthalmol. Vis. Sci.. 2023; 64(10):17. https://doi.org/10.1167/iovs.64.10.17

ARVO Annual Meeting Abstract June 2023

Assessing adaptive optics scanning light ophthalmoscopy (AOSLO) image quality using a model eye phantom

Joseph Kreis; Jessica Wong; Robert F Cooper; Mina Gaffney; Jeremy Rogers; Daniel X Hammer; Jacque L Duncan; Joseph Carroll; Anant Agrawal

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1034.

ARVO Annual Meeting Abstract June 2023

Continuous Intraocular Drug Delivery Lasting Over a Decade: Ciliary Neurotrophic Factor (CNTF) Secreted from Neurotech's NT-501 Implanted in Subjects with Retinal Degenerative Disorders

Konrad Kauper; Lisa Orecchio; Arne Nystuen; Kayla Medeiros; Alice Lee; Vanessa Cavallaro; Jacque L Duncan; Thomas Aaberg

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3680.

ARVO Annual Meeting Abstract June 2023

Change in cone structure over 24 months in USH2A -related retinal degeneration

Jacque L Duncan

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):4645.

ARVO Annual Meeting Abstract June 2023

Worldwide multicenter ocular imaging study (EyeConic) to identify patients eligible for cone-based optogenetics therapy

Lucas Janeschitz-Kriegl; Zoltán Zsolt Nagy; Boris Rosin; Jacque L Duncan; Michel Michaelides; Byron L Lam; Samer Khateb; Katarina Stingl; Kaoru Fujinami; Giacomo Calzetti; Zi-Bing Jin; Karsten Borgwardt; Michael Adamer; Botond Roska; Bence Gyorgy; Hendrik P Scholl

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):5517.

ARVO Annual Meeting Abstract June 2023

Outer retinal reflectivity changes with reduced visual function following anatomically successful repair of macula-off rhegmatogenous retinal detachment

Ajay Kolli; Jessica Wong; Stephanie Duret; Jay M. Stewart; Austin Roorda; Joseph Carroll; Jacque L Duncan

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):4334.

ARVO Annual Meeting Abstract June 2022

Static perimetry over 2 years in the RUSH2A study: annual rates of change from mixed effects modeling

Jacque L Duncan

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):4493 – F0280.

ARVO Annual Meeting Abstract June 2022

Classification and growth rate of retinal atrophy after voretigene neparvovec-rzyl for RPE65-mediated retinal dystrophy

Nikhil Bommakanti; Benjamin Young; Robert Sisk; Audina M. Berrocal; Jacque L Duncan; Benjamin Bakall; Marc Mathias; Aaron Nagiel; Cagri G Besirli

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):456.

ARVO Annual Meeting Abstract June 2022

Worldwide multicenter ocular imaging study (EyeConic) to identify patients eligible for cone-based optogenetics therapy

Lucas Janeschitz-Kriegl; Giacomo Calzetti; Michel Michaelides; Jose Alain Sahel; Zoltán Nagy; Katarina Stingl; Jin Zi-Bing; Jacque L Duncan; Eyal Banin; Byron L Lam; Michalis Georgiou; Boris Rosin; Viktória Szabo; Potyra Rosa; Bence György; Hendrik P Scholl

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):455.

ARVO Annual Meeting Abstract June 2022

Comparison of Retinal Degeneration in GUCY2D- and CRX- related Autosomal Dominant Cone-Rod Dystrophy

Gurbani Kaur; Jessica Wong; Stephanie Duret; Austin Roorda; Jacque L Duncan

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):395 – F0433.

ARVO Annual Meeting Abstract June 2022

Modeling autosomal dominant retinitis pigmentosa associated with copy number variants in rhodopsin and rescue using Photoregulin3 in patient-specific retinal organoids

Sangeetha Kandoi; Cassandra Martinez; Kevin A Xu Chen; Brian Mansfield; Jacque L Duncan; Deepak A Lamba

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1476.

ARVO Annual Meeting Abstract June 2022

Optimizing Variant Curation Guidelines to Improve Clinical Genetic Testing for RPE65 Retinopathies Utilizing the ClinGen Framework

Kristy Lee; Justyne Ross; William Hankey; Andrew R Webster; Lori S Sullivan; Jacque L Duncan; Radha Ayyagari

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2834 – A0350.

ARVO Annual Meeting Abstract June 2022

Adaptive Optics Scanning Laser Ophthalmoscopy (AOSLO) Measures in MERTK-Related Retinal Degenerations

Stephanie Duret; Jessica Wong; Hao Zhou; Ruikang K Wang; Jacque L Duncan; Austin Roorda

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2688.

ARVO Annual Meeting Abstract June 2022

Visual acuity and full-field stimulus thresholds (FST) over 2 years in the RUSH2A study: annual rates of change from mixed effects modeling

Peiyao Cheng; David G Birch; Jacque L Duncan; Frederick L Ferris; Maureen G Maguire; Allison R. Ayala; Janet K Cheetham; Todd Durham; Abigail T Fahim; Rachel M Huckfeldt; Michel Michaelides; Mark E Pennesi; Jose Alain Sahel; Katarina Stingl; Ajoy Vincent; Christina Y Weng

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):4480 – F0267.

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Perimacular Atrophy Following Voretigene Neparvovec-Rzyl Treatment in the Setting of Previous Contralateral Eye Treatment With a Different Viral Vector

Longitudinal Change in Cone Structure and Retinal Sensitivity in Choroideremia

Repeatability and reliability of cone density measures in patients with retinitis pigmentosa (RP) or Usher syndrome using adaptive optics scanning light ophthalmoscopy (AOSLO)

Strategies for Evidence-based Variant Curation for LCA and Early Onset Retinal Dystrophy

PRPH2 Gene Mutations and Associated Phenotypes in IRD patients with diverse genetic background.

Self-Reported Functional Vision in USH2A -Associated Retinal Degeneration as Measured by the Michigan Retinal Degeneration Questionnaire

Enhanced S-Cone Syndrome: Elevated Cone Counts Confer Supernormal Visual Acuity in the S-Cone Pathway

Assessing adaptive optics scanning light ophthalmoscopy (AOSLO) image quality using a model eye phantom

Continuous Intraocular Drug Delivery Lasting Over a Decade: Ciliary Neurotrophic Factor (CNTF) Secreted from Neurotech's NT-501 Implanted in Subjects with Retinal Degenerative Disorders

Change in cone structure over 24 months in USH2A -related retinal degeneration

Worldwide multicenter ocular imaging study (EyeConic) to identify patients eligible for cone-based optogenetics therapy

Outer retinal reflectivity changes with reduced visual function following anatomically successful repair of macula-off rhegmatogenous retinal detachment

Static perimetry over 2 years in the RUSH2A study: annual rates of change from mixed effects modeling

Classification and growth rate of retinal atrophy after voretigene neparvovec-rzyl for RPE65-mediated retinal dystrophy

Worldwide multicenter ocular imaging study (EyeConic) to identify patients eligible for cone-based optogenetics therapy

Comparison of Retinal Degeneration in GUCY2D- and CRX- related Autosomal Dominant Cone-Rod Dystrophy

Modeling autosomal dominant retinitis pigmentosa associated with copy number variants in rhodopsin and rescue using Photoregulin3 in patient-specific retinal organoids

Optimizing Variant Curation Guidelines to Improve Clinical Genetic Testing for RPE65 Retinopathies Utilizing the ClinGen Framework

Adaptive Optics Scanning Laser Ophthalmoscopy (AOSLO) Measures in MERTK-Related Retinal Degenerations

Visual acuity and full-field stimulus thresholds (FST) over 2 years in the RUSH2A study: annual rates of change from mixed effects modeling

To View More...

You must be signed into an individual account to use this feature.